We are live on
!
Find out more
CF
Cantor Fitzgerald Portfolio holdings
AUM
$6.78B
1-Year Est. Return
29.01%
This Fund
S&P 500
This Quarter
Est. Return
+7.21%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.71B
AUM Growth
+$53M
(+1.1%)
Cap. Flow
-$971M
Cap. Flow
% of AUM
-20.64%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
850
New
129
Increased
145
Reduced
185
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BFAC
Battery Future Acquisition Corp.
BFAC
|
+$28.6M |
| 2 |
Meta Platforms (Facebook)
META
|
+$21.6M |
| 3 |
Coca-Cola
KO
|
+$20.6M |
| 4 |
Zimmer Biomet
ZBH
|
+$19.3M |
| 5 |
MBSC
M3-Brigade Acquisition III Corp.
MBSC
|
+$17.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$935M |
| 2 |
AstraZeneca
AZN
|
+$37.6M |
| 3 |
Expeditors International
EXPD
|
+$21.1M |
| 4 |
Costco
COST
|
+$18.9M |
| 5 |
HCA Healthcare
HCA
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.53% |
| 2 | Technology | 16.39% |
| 3 | Healthcare | 9.58% |
| 4 | Industrials | 6.86% |
| 5 | Consumer Discretionary | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.8T
| $100M | 2.13% |
608,317
-57,556
| -9% | -$8.49M |
|
2
RUM Group Inc
RUM
$1.61B
| $95.4M | 2.03% |
10,655,000
-739,000
| -6% | -$6.66M |
|
3
Microsoft
MSFT
$2.99T
| $89.6M | 1.9% |
310,721
-20,566
| -6% | -$5.25M |
|
4
iShares 3-7 Year Treasury Bond ETF
IEI
$18.2B
| $73.9M | 1.57% |
628,026
-25,268
| -4% | -$2.94M |
|
5
iShares Core S&P 500 ETF
IVV
$879B
| $67.8M | 1.44% |
164,893
+18,235
| +12% | +$7.31M |
|
6
Vanguard S&P 500 ETF
VOO
$973B
| $61.7M | 1.31% |
164,059
-3,658
| -2% | -$1.34M |
|
7
Merck
MRK
$307B
| $59.6M | 1.27% |
559,868
-836
| -0.1% | -$90.3K |
|
8
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
| $56.3M | 1.2% |
1,209,820
+22,030
| +2% | +$1.02M |
|
9
Broadcom
AVGO
$1.8T
| $55.3M | 1.18% |
862,080
-11,960
| -1% | -$720K |
|
10
ExxonMobil
XOM
$615B
| $54.3M | 1.15% |
495,061
+2,463
| +0.5% | +$272K |
|
11
Invesco QQQ Trust
QQQ
$463B
| $53.8M | 1.14% |
167,708
-15,718
| -9% | -$4.64M |
|
12
JPMorgan Chase
JPM
$901B
| $52.3M | 1.11% |
401,196
+407
| +0.1% | +$55.8K |
|
13
GCM Grosvenor
GCMG
$773M
| $50.4M | 1.07% |
6,451,535
| – | – |
|
14
Cadence Design Systems
CDNS
$91B
| $42.1M | 0.89% |
200,324
+656
| +0.3% | +$124K |
|
15
CVS Health
CVS
$137B
| $42M | 0.89% |
565,396
+9,249
| +2% | +$776K |
|
16
Vanguard FTSE Developed Markets ETF
VEA
$224B
| $39.3M | 0.84% |
870,158
-29,259
| -3% | -$1.3M |
|
17
United Rentals
URI
$63.4B
| $36.8M | 0.78% |
93,111
-20,634
| -18% | -$8.67M |
|
|
LCW
18
DELISTED
Learn CW Investment Corporation Class A Ordinary Shares
LCW
| $35.2M | 0.75% |
3,427,000
| – | – |
|
19
UnitedHealth
UNH
$383B
| $33.6M | 0.71% |
70,999
-65
| -0.1% | -$31.4K |
|
20
W.R. Berkley
WRB
$27.1B
| $33.1M | 0.7% |
798,522
+817
| +0.1% | +$36.6K |
|
21
Chevron
CVX
$378B
| $32.4M | 0.69% |
198,564
+1,018
| +0.5% | +$171K |
|
22
Gartner
IT
$9.44B
| $32.1M | 0.68% |
98,525
-12,080
| -11% | -$3.99M |
|
23
Fortinet
FTNT
$117B
| $32M | 0.68% |
482,068
+98
| +0% | +$5.57K |
|
24
ProShares UltraPro QQQ
TQQQ
$32.9B
| $29.5M | 0.63% |
2,089,030
+151,614
| +8% | +$1.73M |
|
25
IBM
IBM
$200B
| $29.2M | 0.62% |
222,542
+1,794
| +0.8% | +$240K |
|
Similar funds
JCAM
CIMLRA
TAM
PS
SPC
SPS
BHM
CIA
Cantor Fitzgerald's Q1 2023 Portfolio in Review
As of Q1 2023, Cantor Fitzgerald held 850 positions worth $4.71B, up 1.1% from $4.65B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Cantor Fitzgerald withdrew a net $971M in Q1 2023, closing 179 positions and reducing 185 holdings. Its most notable exit was AstraZeneca, an estimated $37.6M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Cantor Fitzgerald opened a new position in Zimmer Biomet worth $19.8M.
- Cantor Fitzgerald's largest Q1 2023 buy was Zimmer Biomet: 153,493 shares worth $19.8M.
- Cantor Fitzgerald added most to Battery Future Acquisition Corp. in Q1 2023, an estimated $28.6M increase.
- Cantor Fitzgerald's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $935M.
- Cantor Fitzgerald fully exited AstraZeneca in Q1 2023, selling an estimated $37.6M.
- Cantor Fitzgerald's ten largest holdings make up 15% of its $4.71B portfolio in Q1 2023.
- Cantor Fitzgerald opened 129 new positions and closed 179 in Q1 2023.
- Cantor Fitzgerald's portfolio value rose 1.1% quarter-over-quarter to $4.71B.
Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.